Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT03632564
Other study ID # SMC-5167-18
Secondary ID
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date October 10, 2018
Est. completion date August 15, 2019

Study information

Verified date August 2018
Source Visior Technologies Ltd.
Contact Arie Orenstain, Prof.
Phone 972-3-5302993
Email Arie.Orenstain@sheba.health.gov.il
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Modulation of brain blood flow using dichoptic Visual and Auditory stimulation using REVIVIEW system will be evaluated.


Description:

The participant will undergo baseline MRI to measure blood flow in the brain for comparison later on. After baseline MRI, the participant will observe stimulation using the REVIVIEW system for 20 minutes. The content the participants will see is a nature documentary, after which the participant will undergo additional MRI imaging to assess the change in blood flow in the brain.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 10
Est. completion date August 15, 2019
Est. primary completion date July 15, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- healthy subjects

Exclusion Criteria:

- History of brain diseases

- Glasses

- Diagnosed with Diabetes

- Diagnosed with Degenerative brain diseases

- Inability to undergo MRI

Study Design


Related Conditions & MeSH terms


Intervention

Device:
REVIVIEW dichoptic audio-visual stimulation
REVIVIEW dichoptic audio-visual stimulation using video goggles

Locations

Country Name City State
Israel Sheba Medical Center Ramat Gan

Sponsors (1)

Lead Sponsor Collaborator
Visior Technologies Ltd.

Country where clinical trial is conducted

Israel, 

Outcome

Type Measure Description Time frame Safety issue
Primary Change in blood flow in the brain in respond to the stimulation Evaluate the change in blood flow in different parts of the brain, compared with baseline, after the cessation of stimulation, after 30 minutes and after 60 minutes. 1 hour
See also
  Status Clinical Trial Phase
Completed NCT01012674 - Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Phase 3
Completed NCT01010932 - Carotid and Vertebral Magnetic Resonance Angiography (MRA) Study Comparing Dotarem and Time Of Flight (TOF) Phase 3
Recruiting NCT06067113 - Hemodynamic and Functional Characteristics of the Cerebral Circulation in Obesity
Completed NCT04364074 - Acute Probiotic Supplementation and Endothelial Function N/A
Recruiting NCT02914288 - Prospective Observation for Serial Changes of Acute Intracranial Artery Dissection Using High Resolution MRI N/A
Recruiting NCT04265053 - Human Cerebral Blood Flow Regulation Early Phase 1